UBS Group’s Alpine Immune Sciences Inc ALPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-153,473
Closed -$6.08M 10374
2024
Q1
$6.08M Buy
153,473
+87,666
+133% +$2.59M ﹤0.01% 2766
2023
Q4
$1.25M Buy
65,807
+46,760
+245% +$650K ﹤0.01% 4298
2023
Q3
$218K Sell
19,047
-26,803
-58% -$330K ﹤0.01% 5311
2023
Q2
$471K Buy
45,850
+37,857
+474% +$341K ﹤0.01% 4871
2023
Q1
$61.7K Buy
7,993
+5,717
+251% +$45.5K ﹤0.01% 6284
2022
Q4
$16.7K Buy
+2,276
New +$14.5K ﹤0.01% 7879
2022
Q3
Sell
-1,200
Closed -$10K 11195
2022
Q2
$10K Sell
1,200
-1,169
-49% -$10.1K ﹤0.01% 8033
2022
Q1
$22K Sell
2,369
-2,627
-53% -$22.7K ﹤0.01% 7365
2021
Q4
$70K Buy
4,996
+3,854
+337% +$47.7K ﹤0.01% 6633
2021
Q3
$12K Buy
+1,142
New +$10.5K ﹤0.01% 7805
2021
Q2
Sell
-689
Closed -$7K 9960
2021
Q1
$7K Buy
+689
New +$8.59K ﹤0.01% 8176
2020
Q4
Sell
-1,404
Closed -$12K 8875
2020
Q3
$12K Buy
1,404
+288
+26% +$2.63K ﹤0.01% 6718
2020
Q2
$11K Buy
+1,116
New +$4.83K ﹤0.01% 6967
2019
Q3
Sell
-1,129
Closed -$5K 8342
2019
Q2
$5K Buy
1,129
+866
+329% +$5K ﹤0.01% 7400
2019
Q1
$2K Sell
263
-1,413
-84% -$8.81K ﹤0.01% 7477
2018
Q4
$6K Buy
+1,676
New +$8.27K ﹤0.01% 7501
2018
Q3
Sell
-2,137
Closed -$16K 8341
2018
Q2
$16K Buy
2,137
+1,107
+107% +$9.12K ﹤0.01% 6857
2018
Q1
$8K Buy
+1,030
New +$10.2K ﹤0.01% 7020
2017
Q3
Sell
-1,445
Closed -$14K 8073
2017
Q2
$14K Buy
+1,445
New +$13.8K ﹤0.01% 6558
2016
Q4
Sell
-530
Closed -$17K 8110
2016
Q3
$17K Buy
530
+528
+26,400% +$12.9K ﹤0.01% 6441
2016
Q2
$0 Buy
+2
New +$36 ﹤0.01% 8033